QuidelOrtho (QDEL)
(Delayed Data from NSDQ)
$73.45 USD
-2.33 (-3.07%)
Updated Sep 20, 2023 04:00 PM ET
After-Market: $74.00 +0.55 (0.75%) 7:58 PM ET
3-Hold of 5 3
A Value F Growth F Momentum D VGM
Income Statements
Fiscal Year end for QuidelOrtho Corporation falls in the month of December .
All items in Millions except EPS data.
12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 | |
---|---|---|---|---|---|
Sales | 3,266 | 1,699 | 1,662 | 535 | 522 |
Cost Of Goods | 1,330 | 428 | 313 | 214 | 207 |
Gross Profit | 1,936 | 1,271 | 1,349 | 321 | 316 |
Selling & Adminstrative & Depr. & Amort Expenses | 1,092 | 365 | 289 | 228 | 220 |
Income After Depreciation & Amortization | 844 | 906 | 1,060 | 93 | 96 |
Non-Operating Income | -32 | 0 | -10 | -1 | -8 |
Interest Expense | 76 | 6 | 10 | 15 | 24 |
Pretax Income | 736 | 900 | 1,040 | 77 | 63 |
Income Taxes | 187 | 196 | 230 | 4 | -11 |
Minority Interest | 0 | 0 | 0 | 0 | 0 |
Investment Gains/Losses | 0 | 0 | 0 | 0 | 0 |
Other Income/Charges | 0 | 0 | 0 | 0 | 0 |
Income From Cont. Operations | 549 | 704 | 810 | 73 | 74 |
Extras & Discontinued Operations | 0 | 0 | 0 | 0 | 0 |
Net Income (GAAP) | 549 | 704 | 810 | 73 | 74 |
Depreciation Footnote | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 |
---|---|---|---|---|---|
Income Before Depreciation & Amortization | 1,117 | 965 | 1,117 | 154 | 156 |
Depreciation & Amortization (Cash Flow) | 273 | 59 | 56 | 62 | 60 |
Income After Depreciation & Amortization | 844 | 906 | 1,060 | 93 | 96 |
Earnings Per Share Data | 12/31/22 | 12/31/21 | 12/31/20 | 12/31/19 | 12/31/18 |
---|---|---|---|---|---|
Average Shares | 57.40 | 42.87 | 43.59 | 43.11 | 42.55 |
Diluted EPS Before Non-Recurring Items | 13.76 | 17.27 | 19.55 | 2.73 | 2.82 |
Diluted Net EPS (GAAP) | 9.56 | 16.43 | 18.60 | 1.73 | 1.86 |
Fiscal Year end for QuidelOrtho Corporation falls in the month of December .
All items in Millions except EPS data.
6/30/23 | 3/31/23 | 12/31/22 | 9/30/22 | 6/30/22 | |
---|---|---|---|---|---|
Sales | 665.10 | 846.10 | 866.54 | 783.80 | 613.40 |
Cost Of Goods | 368.70 | 397.50 | 415.50 | 376.30 | 275.90 |
Gross Profit | 296.40 | 448.60 | 451.04 | 407.50 | 337.50 |
SG&A, R&D, and Dept/Amort Expenses | 323.30 | 349.00 | 364.50 | 350.70 | 257.80 |
Income After SG&A, R&D, and Dept/Amort Expenses | -26.90 | 99.60 | 86.54 | 56.80 | 79.70 |
Non-Operating Income | -1.00 | -2.90 | -9.80 | 4.20 | -26.50 |
Interest Expense | 36.50 | 36.70 | 35.67 | 29.70 | 10.30 |
Pretax Income | -64.40 | 60.00 | 41.07 | 31.30 | 42.90 |
Income Taxes | -11.20 | 11.20 | 10.81 | 12.10 | 23.60 |
Minority Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Investment Gains/Losses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Income/Charges | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Income From Cont. Operations | -53.20 | 48.80 | 30.26 | 19.20 | 19.30 |
Extras & Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Income (GAAP) | -53.20 | 48.80 | 30.26 | 19.20 | 19.30 |
Earnings Per Share Data | 6/30/23 | 3/31/23 | 12/31/22 | 9/30/22 | 6/30/22 |
---|---|---|---|---|---|
Average Shares | 66.80 | 67.10 | 66.90 | 67.50 | 52.90 |
Diluted EPS Before Non-Recurring Items | 0.26 | 1.79 | 1.74 | 1.83 | 2.11 |
Diluted Net EPS (GAAP) | -0.80 | 0.73 | -2.39 | 0.28 | 0.36 |